Immutrin Ltd

12217886 · Active · incorporated 6 years, 10 months ago · Cambridge

Biotech Biotech & Life Sciences Drug Discovery Series B+

Develops next-generation antibody therapies for the treatment of amyloidosis, including ATTR cardiomyopathy.

https://www.immutrin.com/

£27m
Total raised
5
Funding rounds
7
Shareholders on register
65
Filings tracked · 1mo ago

The full picture is one free sign-up away

See the complete cap table with every shareholder, founder tags, dilution across 8 share allotments, round-by-round fundraising history, and the full filing timeline — parsed from official Companies House documents.

Create a free account Sign in

Free accounts open 3 companies in full detail — no card required.